Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Journal of Experimental Medicine

Volumn 196, Issue 8, 2002, Pages 1025-1037

  Serhan, Charles N ^a   Hong, Song ^a   Gronert, Karsten ^a   Colgan, Sean P ^a   Devchand, Pallavi R ^a   Mirick, Gudrun ^a   Moussignac, Rose Laure ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cyclooxygenase 2; Docosahexaenoic acid; Endothelial cells; Leukocytes; Resolution

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; CYTOKINE; DOCOSAHEXAENOIC ACID; ICOSANOID; OMEGA 3 FATTY ACID; RESOLVIN; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE; MALE; MICROGLIA; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN INFLAMMATION;

ANIMALS; ASPIRIN; BIOLOGICAL FACTORS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; MICE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0037152160     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020760     Document Type: Article

References (59)

1. Clària, J., and C.N. Serhan. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA. 92:9475-9479.
2. Serhan, C.N., C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192:1197-1204.
3. Samuelsson, B. 1982. From studies of biochemical mechanisms to novel biological mediators: Prostaglandin endoperoxides, thromboxanes and leukotrienes. In Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures. Almqvist & Wiksell, Stockholm. 153-174.
4. Samuelsson, B., S.E. Dahlén, J.Å. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176.
5. Gunstone, F.D., J.L. Harwood, and F.B. Padley, editors. 1994. The Lipid Handbook. 2nd Ed. Chapman & Hall, London. pp. 1-1273.
6. Zeldin, D.C. 2001. Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276:36059-36062.
7. Marcus, A.J. 1999. Platelets: Their role in hemostasis, thrombosis, and inflammation. In Inflammation: Basic Principles and Clinical Correlates. J.I. Gallin and R. Snyderman, editors. Lippincott Williams & Wilkins, Philadelphia. 77-95.
8. 4 synthesis. In Cell-Cell Interactions in the Release of Inflammatory Mediators. P.Y.-K. Wong and C.N. Serhan, editors. Plenum, New York. 73-89.
9. Serhan, C.N., and E. Oliw. 2001. Unorthodox routes to prostanoid formation: New twists in cyclooxygenase-initiated pathways. J. Clin. Invest. 107:1481-1489.
10. Levy, B.D., C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan. 2001. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat. Immunol. 2:612-619.
11. McMahon, B., S. Mitchell, H.R. Brady, and C. Godson. 2001. Lipoxins: Revelations on resolution. Trends Pharmacol. Sci. 22:391-395.
12. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: Relationship with concurrent eosinophilia. J. Immunol. 164:1029-1036.
13. Canny, G., O. Levy, G.T. Furuta, S. Narravula-Alipati, R.B. Sisson, C.N. Serhan, and S.P. Colgan. 2002. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. USA. 99:3902-3907.
14. Rowley, A.F., D.J. Hill, C.E. Ray, and R. Munro. 1997. Haemostasis in fish-an evolutionary perspective. Thromb. Haemost. 77:227-233.
15. De Caterina, R., S. Endres, S.D. Kristensen, and E.B. Schmidt, editors. 1993. N-3 Fatty Acids and Vascular Disease. Springer-Verlag, London. pp. 1-166.
16. Hibbeln, J.R. 1998. Fish consumption and major depression. Lancet. 351:1213.
17. Olfson, M., S.C. Marcus, B. Druss, L. Elinson, T. Tanielian, and H.A. Pincus. 2002. National trends in the outpatient treatment of depression. JAMA. 287:203-209.
18. Albert, C.M., H. Campos, M.J. Stampfer, P.M. Ridker, J.E. Manson, W.C. Willett, and J. Ma. 2002. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346:1113-1118.
19. Shinmura, K., X.-L. Tang, Y. Wang, Y.-T. Xuan, S.-Q. Liu, H. Takano, A. Bhatnagar, and R. Bolli. 2000. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc. Natl. Acad. Sci. USA. 97:10197-10202.
20. Marchioli, M. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico. Lancet. 354:447-455.
21. Marchioli, R., F. Barzi, E. Bomba, C. Chieffo, D. Di Gregorio, R. Di Mascio, M.G. Franzosi, E. Geraci, G. Levantesi, A.P. Maggioni, et al. 2002. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico (GISSI)-prevenzione. circulation. 105:1897-1903.
22. McLennan, P., P. Howe, M. Abeywardena, R. Muggli, D. Raederstorff, M. Mano, T. Rayner, and R. Head. 1996. The cardiovascular protective role of docosahexaenoic acid. Eur. J. Pharmacol. 300:83-89.
23. Libby, P. 2002. Atherosclerosis: The new view. Sci. Am. 286:46-55.
24. Drazen, J.M., E.K. Silverman, and T.H. Lee. 2000. Heterogeneity of therapeutic responses in asthma. Br. Med. Bull. 56:1054-1070.
25. Vane, J.R., and R.M. Botting, editors. 2001. Therapeutic Roles of Selective COX-2 Inhibitors. William Harvey Press, London. pp. 1-584.
26. Rowlinson, S.W., B.C. Crews, D.C. Goodwin, C. Schneider, J.K. Gierse, and L.J. Marnett. 2000. Spatial requirements for 15-(R)-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. J. Biol. Chem. 275:6586-6591.
27. Gilroy, D.W., P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark, and D.A. Willoughby. 1999. Inducible cycloxygenase may have anti-inflammatory properties. Nat. Med. 5:698-701.
28. Bazan, N.G., E.B. Rodriguez de Turco, and W.C. Gordon. 1993. Pathways for the uptake and conservation of docosahexaenoic acid in photoreceptors and synapses: Biochemical and autoradiographic studies. Can. J. Physiol. Pharmacol. 71:690-698.
29. Whelan, J., P. Reddanna, V. Nikolaev, G.R. Hildenbrandt, and T.S. Reddy. 1990. The unique characteristics of the purified 5-lipoxygenase from potato tubers and the proposed mechanism of formation of leukotrienes and lipoxins. In Biological Oxidation Systems. Academic Press, San Diego. 765-778.
30. Fischer, S., C.V. Schacky, W. Siess, T. Strasser, and P.C. Weber. 1984. Uptake, release and metabolism of docosahexaenoic acid (DHA, C22:6ω3) in human platelets and neutrophils. Biochem. Biophys. Res. Commun. 120:907-918.
31. Lee, T.H., J.-M. Mencia-Huerta, C. Shih, E.J. Corey, R.A. Lewis, and K.F. Austen. 1984. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest. 74:1922-1933.
32. Yergey, J.A., H.-Y. Kim, and N. Salem, Jr. 1986. High-performance liquid chromatography/thermospray mass spectrometry of eicosanoids and novel oxygenated metabolites of docosahexaenoic acid. Anal. Chem. 58:1344-1348.
33. 4 metabolic inactivation. J. Biol. Chem. 275:25372-25380.
34. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92:75-82.
35. George, H.J., D.E. Van Dyk, R.A. Straney, J.M. Trzaskos, and R.A. Copeland. 1996. Expression purification and characterization of recombinant human inducible prostaglandin G/H synthase from baculovirus-infected insect cells. Protein Expres. Purif. 7:19-26.
36. Gronert, K., C.B. Clish, M. Romano, and C.N. Serhan. 1999. Transcellular regulation of eicosanoid biosynthesis. In Eicosanoid Protocols. E.A. Lianos, editor. Humana Press, Totowa, NJ. 119-144.
37. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry. 34:14609-14615.
38. 4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J. 15:2736-2738.
39. Cotran, R.S., V. Kumar, and T. Collins. 1999. Cellular pathology I: Cell injury and cell death. In Robbins Pathologic Basis of Disease. R.S. Cotran, V. Kumar and T. Collins, editors. W.B. Saunders, Philadelphia. 1-29.
40. Sawazaki, S., N. Salem, Jr., and H.-Y. Kim. 1994. Lipoxygenation of docosahexaenoic acid by the rat pineal body. J. Neurochem. 62:2437-2447.
41. Miller, C.C., W. Tang, V.A. Ziboh, and M.P. Fletcher. 1991. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative antiinflammatory metabolites. J. Invest. Dermatol. 96:98-103.
42. Xiao, G., A.-L. Tsai, G. Palmer, W.C. Boyar, P.J. Marshall, and R.J. Kulmacz. 1997. Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2. Biochemistry. 36:1836-1845.
43. Corey, E.J., C. Shih, and J.R. Cashman. 1983. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. USA. 80:3581-3584.
44. O'Banion, M.K., V.D. Winn, and D.A. Young. 1992. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA. 89:4888-4892.
45. Schmedtje, J.F., Jr., Y.-S. Ji, W.-L. Liu, R.N. DuBois, and M.S. Runge. 1997. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272:601-608.
46. 4 synthesis from arachidonic acid. Proc. Natl. Acad. Sci. USA. 81:689-693.
47. Ziboh, V.A., C.C. Miller, and Y. Cho. 2000. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: Generation of antiinflammatory and antiproliferative metabolites. Am. J. Clin. Nutr. 71:361S-366S.
48. Simopoulos, A.P., A. Leaf, and N. Salem, Jr. 1999. Workshop on the essentiality of an recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 18:487-489.
49. Salem, N., Jr., B. Wegher, P. Mena, and R. Uauy. 1996. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl. Acad. Sci. USA. 93:49-54.
50. Tou, J.-S. 1986. Acylation of docosahexaenoic acid into phospholipids by intact human neutrophils. Lipids. 21:324-327.
51. + channels: Subunit selective antagonism by zinc. Neuropharmacology. 35:969-982.
52. Mata de Urquiza, A., S. Liu, M. Sjöberg, R.H. Zetterström, W. Griffiths, J. Sjövall, and T. Perlmann. 2000. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 290:2140-2144.
53. -/- mice and the effect of docosahexaenoic acid. J. Appl. Physiol. 92:2169-2176.
54. 4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry. 39:2376-2383.
55. Lands, W.E.M. editor. 1987. Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids. American Oil Chemists' Society, Champaign, IL. pp. 1-574.
56. Garcia-Cardena, G., J. Comander, K.R. Anderson, B.R. Blackman, and M.A. Gimbrone, Jr. 2001. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. USA. 98:4478-4485.
57. Gum, P.A., M. Thamilarasan, J. Watanabe, E.H. Blackstone, and M.S. Lauer. 2001. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. JAMA. 286:1187-1194.
58. Rosenberg, I.H. 2002. Fish-food to calm the heart. N. Engl. J. Med. 346:1102-1103.
59. 4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183:137-146.